CN1307882A - 一种治疗血液病的药 - Google Patents
一种治疗血液病的药 Download PDFInfo
- Publication number
- CN1307882A CN1307882A CN00131239A CN00131239A CN1307882A CN 1307882 A CN1307882 A CN 1307882A CN 00131239 A CN00131239 A CN 00131239A CN 00131239 A CN00131239 A CN 00131239A CN 1307882 A CN1307882 A CN 1307882A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- radix
- grams
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 45
- 229940079593 drug Drugs 0.000 title description 5
- 210000000582 semen Anatomy 0.000 claims abstract description 17
- 241001116389 Aloe Species 0.000 claims abstract description 8
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 claims abstract description 8
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 8
- 210000002826 placenta Anatomy 0.000 claims abstract description 8
- 229910052957 realgar Inorganic materials 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 241000411851 herbal medicine Species 0.000 claims abstract description 5
- 241000490229 Eucephalus Species 0.000 claims abstract description 3
- 238000002360 preparation method Methods 0.000 claims description 10
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 claims description 7
- 244000035851 Chrysanthemum leucanthemum Species 0.000 claims description 7
- 241000190633 Cordyceps Species 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 6
- 230000007423 decrease Effects 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 235000001405 Artemisia annua Nutrition 0.000 abstract 1
- 240000000011 Artemisia annua Species 0.000 abstract 1
- 206010004542 Bezoar Diseases 0.000 abstract 1
- 241001073507 Callicarpa Species 0.000 abstract 1
- 240000006766 Cornus mas Species 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 abstract 1
- 241000096284 Gynochthodes officinalis Species 0.000 abstract 1
- 241001248610 Ophiocordyceps sinensis Species 0.000 abstract 1
- 235000008282 Sanguisorba officinalis Nutrition 0.000 abstract 1
- 244000173853 Sanguisorba officinalis Species 0.000 abstract 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract 1
- 244000126002 Ziziphus vulgaris Species 0.000 abstract 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract 1
- 210000003056 antler Anatomy 0.000 abstract 1
- 235000007215 black sesame Nutrition 0.000 abstract 1
- SURQXAFEQWPFPV-UHFFFAOYSA-L iron(2+) sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+2].[O-]S([O-])(=O)=O SURQXAFEQWPFPV-UHFFFAOYSA-L 0.000 abstract 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 abstract 1
- 239000004071 soot Substances 0.000 abstract 1
- 102000001554 Hemoglobins Human genes 0.000 description 6
- 108010054147 Hemoglobins Proteins 0.000 description 6
- 208000032467 Aplastic anaemia Diseases 0.000 description 5
- 208000002903 Thalassemia Diseases 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 208000007502 anemia Diseases 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000012907 honey Nutrition 0.000 description 4
- 208000032839 leukemia Diseases 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 208000036581 Haemorrhagic anaemia Diseases 0.000 description 3
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 3
- 206010043561 Thrombocytopenic purpura Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 208000007475 hemolytic anemia Diseases 0.000 description 3
- 230000002607 hemopoietic effect Effects 0.000 description 3
- 210000002751 lymph Anatomy 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 208000036654 deficiency anemia Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010015993 Eyelid oedema Diseases 0.000 description 1
- 206010018276 Gingival bleeding Diseases 0.000 description 1
- 208000024283 Gingival haemorrhages Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 206010041660 Splenomegaly Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 238000010322 bone marrow transplantation Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- -1 electuary Substances 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 206010024378 leukocytosis Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000030208 low-grade fever Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 238000010911 splenectomy Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000000216 zygoma Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
一种以中草药为原料配制成治疗血液病的药,各组分配比的重量份是:鹿茸2-10,冬虫夏草3-10,紫河车5-10,山茱萸5-20,巴戟天5-30,补骨脂5-30,菟丝子5-20,沙菀子5-20,百草霜5-50,黑脂麻5-50,熟地5-20,黄精5-20,绿矾2-25,地榆5-30,大枣5-50,牛黄1-10,青黛2-15,升麻5-40,雄黄1-10,芦荟1-10,青蒿5-20,紫珠草5-30,鸡血藤5-50,大小蓟5-30,野菊花根5-30,花粉5-30,黄芩5-30,大黄5-20,或再加入川芎5-30,丹皮5-30。
Description
本发明涉及医用配制品,具体是以中草药为原料配制成治疗血液病的药物。
血液病在临床分类上有营养性贫血、缺铁性贫血、出血性贫血、溶血性贫血、血小板减少性紫癜和再生障碍性贫血、地中海贫血以及白血病等,是由于骨髓组织异常而引起的造血功能不足或衰竭造成。血液病临床表现主要是贫血,牙龈出血,毕衄,皮下紫癜,头晕乏力,心悸气短,感染发热,肝脾、淋巴肿大等症状及体征,轻者影响健康,重则危及生命。特别是再生障碍性贫血、地中海贫血和白血病,治疗难度大,即使输血、化疗、放疗甚至骨髓移植或脾脏切除,疗效也未必理想。中医方面,长期以来也一直进行探索和研究,但直至目前,尚未有一种治疗血液病疗效比较满意的中成药。
本发明的目的在于提供一种对血液病疗效显著,由中草药为原料制成的药物。
为了实现上述之目的,本发明根据“邪之所凑,其正必虚”和“髓海瘀阻”的病因病机和脾肾元气与造血的关系,针对血液病症候复杂和多种疾病并存的情况,采取“滋补脾肾,填髓生血,清热解毒,消瘀止血”相结合。选用具有补气滋阴的鹿茸、冬虫夏草、紫河车、山茱萸、巴戟天、补骨脂、菟丝子、河菀子、百草霜、黑脂麻、绿矾、熟地、黄精、地榆、大枣等为扶正佳品;以具有清热解毒、消瘀止血的牛黄、青黛、升麻、芦荟、花粉、黄苓、雄黄、大黄、青蒿、紫珠草、鸡血藤、大小蓟、野菊花根等为祛邪和辅助用药,共同配制成本发明治疗血液病药物。
本发明治疗血液病的药物是由以下重量份的中草药为原料制备而成:鹿茸2-10,冬虫夏草3-10,紫河车5-10,山茱萸5-20,巴戟天5-30,补骨脂5-30,菟丝子5-20,沙菀子5-20,百草霜5-50,黑脂麻5-50,熟地5-20,黄精5-20,绿矾2-25,地榆5-30,大枣5-50,牛黄1-10,青黛2-15,升麻5-40,雄黄1-10,芦荟1-10,青蒿5-20,紫珠草5-30,鸡血藤5-50,大小蓟5-30,野菊花根5-30,花粉5-30,黄苓5-30,大黄5-20,或再加入川芎5-30,丹皮5-30。
上述制备本发明治疗血液病药物的原料组按常规的制剂工艺制备成各种常用药剂,如丸剂,粉剂,冲剂,片剂,胶囊或水剂。
如前所述,血液病包括多种,各种不同的血液病在使用本发明药物时用药种类也有区别,因此,在制备本发明药物时,可将上述组分分别制成A、B两型制剂,其中A型包括鹿茸、冬虫夏草、紫河车、山茱萸、巴戟天、补骨脂,菟丝子、沙菀子、百草霜、黑脂麻、绿矾、熟地、黄精、地榆、大枣等扶正药物或增减;B型包括牛黄、青黛、升麻、芦荟、花粉、黄苓、雄黄、大黄、青蒿、紫珠草、鸡血藤、大小蓟、野菊花根等祛邪药物或增减。使用时,营养性贫血、缺铁性贫血,出血性贫血,溶血性贫血,血小板减少性紫癜等血液病仅服用A型药物即可。而再生障碍性贫血,地中海贫血和白血病等血液病除服用A型药物外,还须服用B型药物。
临床验证表明,本发明药物对缓解贫血症状,提高血红蛋白,增进食欲,增强体质,退热,止血,促进骨髓造血功能,延长生命质量等方面具有显著疗效,且未发现任何毒副作用。
以下结合实施例对本发明作进一步阐述。
实施例1:
称取鹿茸15克,冬虫夏草20克,紫河车30克,巴戟天30克,补骨脂30克,菟丝子30克,沙菀子30克,百草霜50克,黑脂麻50克,熟地黄40克,黄精30克,绿矾20克,地榆30克,大枣50克,山茱萸30克。将上述药物焙干研末,加蜜适量制成绿豆大小蜜丸。即成A型药物。
称取牛黄8克,青黛30克,升麻60克,青蒿30克,花粉20克,芦荟15克,雄黄10克,大黄20克,黄苓50克,川芎40克,丹皮30克,野菊花根50克,大小蓟50克,鸡血藤90克,紫珠草30克。将上述药物焙干研末,制成颗粒,装入胶囊,每粒0.3克,即成B型药物。
实施例2:
称取鹿茸10克,冬虫夏草10克,紫河车10克,巴戟天30克,补骨脂30克,菟丝子20克,沙菀子20克,百草霜50克,黑脂麻50克,熟地20克,黄精20克,绿矾25克,地榆30克,大枣50克,大小蓟30克,鸡血藤50克,山茱萸30克,将上述药物焙干研末,加蜜适量制成绿豆大小蜜丸,即成A型药物。
称取牛黄10克,青黛15克,升麻40克,青蒿20克,花粉30克,芦荟10克,雄黄10克,大黄20克,黄苓30克,野菊花根15克,川芎40克,丹皮30克。将上述药物焙干研末,制成颗粒,装入胶囊,每粒0.3克,即得B型药物。
以上实施例A、B药物在服用时,营养性贫血,缺铁性贫血,出血性贫血,溶血性贫血,血小板减少性紫癜等血液病仅服用A型药,每日服药3次,每次6克,2-3周为一疗程。再生障碍性贫血,地中海贫血和白血病等血液病除了每日3次,每次6克服用A型药外,还须同时服用B型药,用量为每日3次,每次3克,3-4周为一疗程。
典型病例介绍:
1.李某,女,35岁,干部。患血崩病症年作,曾两次住院治疗,病状改善不大。长期头晕,心悸,血红蛋白一直在6克以下,两个月前再次发病,血红蛋白3.8克。服用本发明A型药物3周,症状基本消失,血红蛋白升到8.9克。
2.蒙某,男,40岁,大队支书。反复低热,牙龈肿胀出血,盗汗乏力年余,到地市级医院检查白细胞增多,脾脏及颈部淋巴肿大,诊为慢性粒细胞白血病,经化疗及服用西药近半年未见缓解。服用本发明A、B两种药物壹个半月后,上述症状消失,脾脏缩小,颈部淋巴已摸不到。患者已能恢复劳动能力,追踪至今已达10年未见复发。
3.刘某,女,38岁,农民。因眼皮浮肿,黄疸,消瘦,精神不振到某大医院就医,经检查肝、脾肿大,血红蛋白电脉示HbA2为3.7%,明显鼻梁塌陷,颧骨高耸,诊断为地中海贫血。经输血,打针未见好转。服用本发明A、B药物3周后症状明显好转。继续服药两周后已能胜任家务和参加一般农活。复查血红蛋白已提高到8.6克。
4.张某,男,51岁,教师。因患“再障”贫血,经输血多次,长期服用西药未愈。服用本发明A、B两药物1个月,疗效显著。
Claims (2)
1.一种治疗血液病的药,其特征是由以下重量份的中草药为原料按传统制剂工艺制成丸剂或粉剂或冲剂或片剂或胶囊或水剂:鹿茸2-10,冬虫夏草3-10,紫河车5-10,山茱萸5-20,巴戟天5-30,补骨脂5-30,菟丝子5-20,河菀子5-20,百草霜5-50,黑脂麻5-50,熟地5-20,黄精5-20,绿矾2-25,地榆5-30,大枣5-50,牛黄1-10,青黛2-15,升麻5-40,雄黄1-10,芦荟1-10,青蒿5-20,紫珠草5-30,鸡血藤5-50,大小蓟5-30,野菊花根5-30,花粉5-30,黄苓5-30,大黄5-20,或再加入川芎5-30,丹皮5-30。
2.按照权利要求1所述治疗血液病的药,其特征是将药物分成A、B两型制剂,A型包括鹿茸,冬虫夏草,紫河车,山茱萸,巴戟天,补骨脂,菟丝子,沙菀子,百草霜,黑脂麻,绿矾,熟地,黄精,地榆,大枣等扶正药物或增减;B型包括牛黄,青黛,升麻,芦荟,花粉,黄苓,雄黄,大黄,青蒿,紫珠草,鸡血藤,大小蓟,野菊花根等祛邪药物或增减。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB001312391A CN1146437C (zh) | 2000-12-08 | 2000-12-08 | 一种治疗血液病的药 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB001312391A CN1146437C (zh) | 2000-12-08 | 2000-12-08 | 一种治疗血液病的药 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1307882A true CN1307882A (zh) | 2001-08-15 |
CN1146437C CN1146437C (zh) | 2004-04-21 |
Family
ID=4594574
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB001312391A Expired - Fee Related CN1146437C (zh) | 2000-12-08 | 2000-12-08 | 一种治疗血液病的药 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1146437C (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100358567C (zh) * | 2003-04-22 | 2008-01-02 | 吴新胜 | 一种用于生发乌发的中西药复方制剂 |
CN101869609A (zh) * | 2010-06-29 | 2010-10-27 | 杜晓燕 | 一种气血双补药物及其制备方法与应用 |
CN101164572B (zh) * | 2006-10-18 | 2010-11-10 | 谢继业 | 治疗乙型病毒性肝炎的口服药物 |
CN103028086A (zh) * | 2012-12-20 | 2013-04-10 | 周瑾 | 一种治疗缺铁性贫血的中药药丸 |
CN103070968A (zh) * | 2013-02-07 | 2013-05-01 | 陈炳桂 | 一种治疗白血病的中药丸及其制备方法 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100393346C (zh) * | 2005-12-21 | 2008-06-11 | 沈信堂 | 一种治疗白血病的中药 |
-
2000
- 2000-12-08 CN CNB001312391A patent/CN1146437C/zh not_active Expired - Fee Related
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100358567C (zh) * | 2003-04-22 | 2008-01-02 | 吴新胜 | 一种用于生发乌发的中西药复方制剂 |
CN101164572B (zh) * | 2006-10-18 | 2010-11-10 | 谢继业 | 治疗乙型病毒性肝炎的口服药物 |
CN101869609A (zh) * | 2010-06-29 | 2010-10-27 | 杜晓燕 | 一种气血双补药物及其制备方法与应用 |
CN103028086A (zh) * | 2012-12-20 | 2013-04-10 | 周瑾 | 一种治疗缺铁性贫血的中药药丸 |
CN103028086B (zh) * | 2012-12-20 | 2014-06-04 | 周瑾 | 一种治疗缺铁性贫血的中药药丸 |
CN103070968A (zh) * | 2013-02-07 | 2013-05-01 | 陈炳桂 | 一种治疗白血病的中药丸及其制备方法 |
CN103070968B (zh) * | 2013-02-07 | 2014-04-09 | 陈炳桂 | 一种治疗白血病的中药丸及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1146437C (zh) | 2004-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1323673C (zh) | 一种治疗上呼吸道感染的药物配方及其设计方法 | |
CN101461921B (zh) | 一种治疗妇科疾病的药物组合物 | |
CN102755594A (zh) | 一种治疗急慢性乙肝的中药组合物及其制备方法 | |
CN1305483C (zh) | 一种调节心衰的中药药物 | |
CN102488743B (zh) | 中药组合物、制备方法及中药制剂 | |
CN1146437C (zh) | 一种治疗血液病的药 | |
CN101530515B (zh) | 一种治疗糖尿病并发前列腺肿大的中药 | |
CN103520659B (zh) | 一种治疗癌症的中药 | |
CN1289114C (zh) | 痹痛丸及其制备方法 | |
CN102657736B (zh) | 一种治疗类风湿性关节炎的药物组合物及其制备方法 | |
CN103182059A (zh) | 一种治疗慢性胃炎的中药组合物及其应用 | |
CN102631518B (zh) | 一种治疗血癌的新药 | |
CN1052889C (zh) | 一种治疗肝炎的中成药 | |
CN104524537A (zh) | 一种治疗慢性肠炎的药物组合物 | |
CN102885953A (zh) | 一种用于补肾健脾的中药制剂及其制备工艺 | |
CN1059117C (zh) | 蝎毒肿瘤丸及其制备方法 | |
CN1876148A (zh) | 一种益肾健骨的中药组合物及其制备方法 | |
CN103877509B (zh) | 一种治疗白血病的药物及其制备方法 | |
CN101693096A (zh) | 一种治疗肝癌的药物及其制备方法 | |
CN114306497B (zh) | 一种治疗肾虚血瘀型骨质疏松症的中药组合物、制剂与应用 | |
CN101829213B (zh) | 治疗哮喘的药物组合物及其制备方法 | |
CN101537125B (zh) | 一种治疗子宫癌的中药 | |
CN111110782B (zh) | 一种中药组合物在制备治疗感冒药物中的应用 | |
CN101375965A (zh) | 治疗进行期复发性银屑病的中药蜜丸 | |
CN1064536C (zh) | 治疗ⅳ期胃癌的药品及其制作方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |